Gangwon, South Korea

Jee-Yin Ahn

This inventor holds 1 USPTO granted patent. Top assignee: Immunemed Inc.. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jee-Yin Ahn. Retrieved from https://idiyas.com/inventor/jee-yin-ahn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jee-Yin Ahn

Introduction

Jee-Yin Ahn is a notable inventor based in Gangwon-do, South Korea. He has made significant contributions to the field of virology through his innovative research and development of antiviral agents. His work focuses on creating solutions for viral infections that affect both humans and animals.

Latest Patents

One of Jee-Yin Ahn's key patents is the "Anti-viral VSF protein and hybridoma producing the same." This patent discloses a novel virus suppressing factor (VSF) protein that exhibits antiviral activity against a variety of viruses. The invention also includes a hybridoma that secretes this VSF protein. Furthermore, it presents a pharmaceutical composition that utilizes the VSF protein for the prevention or treatment of viral infections. The VSF protein demonstrates strong antiviral activity, making it a promising candidate for therapeutic applications.

Career Highlights

Jee-Yin Ahn is associated with Immunemed Inc., where he continues to advance his research in antiviral therapies. His work has garnered attention for its potential impact on public health, particularly in combating viral diseases.

Collaborations

Jee-Yin Ahn collaborates with esteemed colleagues, including Yoon-Won Kim and Young-Jin Kim. Their combined expertise enhances the research efforts at Immunemed Inc. and contributes to the development of innovative solutions in virology.

Conclusion

Jee-Yin Ahn's contributions to the field of antiviral research are noteworthy, particularly through his patented VSF protein. His work at Immunemed Inc. and collaborations with fellow researchers position him as a key figure in the fight against viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…